Palatin Technologies Inc (PTN)
1.20
0.00 (0.00%)
USD |
NYAM |
Nov 12, 16:00
1.19
-0.01
(-0.83%)
After-Hours: 20:00
Palatin Technologies Research and Development Expense (Quarterly): 4.672M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.672M |
| March 31, 2024 | 7.160M |
| December 31, 2023 | 5.554M |
| September 30, 2023 | 5.015M |
| June 30, 2023 | 7.406M |
| March 31, 2023 | 4.830M |
| December 31, 2022 | 4.368M |
| September 30, 2022 | 6.027M |
| June 30, 2022 | 7.436M |
| March 31, 2022 | 4.980M |
| December 31, 2021 | 5.426M |
| September 30, 2021 | 3.485M |
| June 30, 2021 | 3.482M |
| March 31, 2021 | 2.510M |
| December 31, 2020 | 4.011M |
| September 30, 2020 | 2.924M |
| June 30, 2020 | 3.933M |
| March 31, 2020 | 3.641M |
| December 31, 2019 | 3.258M |
| September 30, 2019 | 3.128M |
| June 30, 2019 | 4.329M |
| March 31, 2019 | 3.944M |
| December 31, 2018 | 2.962M |
| September 30, 2018 | 3.623M |
| June 30, 2018 | 5.288M |
| Date | Value |
|---|---|
| March 31, 2018 | 7.069M |
| December 31, 2017 | 6.046M |
| September 30, 2017 | 14.16M |
| June 30, 2017 | 17.26M |
| March 31, 2017 | 9.062M |
| December 31, 2016 | 8.135M |
| September 30, 2016 | 11.23M |
| June 30, 2016 | 10.52M |
| March 31, 2016 | 10.68M |
| December 31, 2015 | 11.27M |
| September 30, 2015 | 10.60M |
| June 30, 2015 | 9.774M |
| March 31, 2015 | 7.588M |
| December 31, 2014 | 4.274M |
| September 30, 2014 | 2.924M |
| June 30, 2014 | 2.596M |
| March 31, 2014 | 2.151M |
| December 31, 2013 | 2.630M |
| September 30, 2013 | 3.449M |
| June 30, 2013 | 2.795M |
| March 31, 2013 | 2.945M |
| December 31, 2012 | 2.446M |
| September 30, 2012 | 2.343M |
| June 30, 2012 | 4.130M |
| March 31, 2012 | 4.706M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.510M
Minimum
Mar 2021
7.436M
Maximum
Jun 2022
4.743M
Average
4.672M
Median
Jun 2024
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.009M |
| iBio Inc | 1.14M |
| Theriva Biologics Inc | 2.953M |
| Oragenics Inc | 0.9068M |
| Nanoviricides Inc | 1.182M |